{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["TGF-\u03b2 signaling pathway", "invasion", "miR-34b", "migration", "prostate cancer"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29257105", "DateCompleted": {"Year": "2018", "Month": "07", "Day": "17"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "27"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "12", "Day": "19"}], "Language": ["eng"], "ELocationID": ["2762", "10.3390/ijms18122762"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "18", "Issue": "12", "PubDate": {"Year": "2017", "Month": "Dec", "Day": "19"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Potent Inhibition of miR-34b on Migration and Invasion in Metastatic Prostate Cancer Cells by Regulating the TGF-\u03b2 Pathway.", "Abstract": {"AbstractText": ["The importance of miRNAs in the progression of prostate cancer (PCa) has further been supported by the finding that miRNAs have been identified as potential oncogenes or tumor suppressors in PCa. Indeed, in eukaryotes, miRNAs have been found to regulate and control gene expression by degrading mRNA at the post-transcriptional level. In this study, we investigated the expression of miR-34 family members, miR-34b and miR-34c, in different PCa cell lines, and discussed the molecular mechanism of miR-34b in the invasion and migration of PCa cells in vitro. The difference analyses of the transcriptome between the DU145 and PC3 cell lines demonstrated that both miR-34b and -34c target critical pathways that are involved in metabolism, such as proliferation, and migration, and invasion. The molecular expression of miR-34b/c were lower in PC3 cells. Moreover, over-expression of miR-34b/c in PC3 cells caused profound phenotypic changes, including decreased cell proliferation, migration and invasion. Moreover, the players that regulate expression levels of transforming growth factor-\u03b2 (TGF-\u03b2), TGF-\u03b2 receptor 1 (TGF-\u03b2R1), and p53 or phosphorylation levels of mothers against decapentaplegic 3 (SMAD3) in the TGF-\u03b2/Smad3 signaling pathway have yet to be elucidated, and will provide novel tools for diagnosis and treatment of metastatic PCa."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China. fanglili990538@163.com."}, {"Identifier": [], "Affiliation": "Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550002, China. fanglili990538@163.com."}, {"Identifier": [], "Affiliation": "Department of Anatomy, Guizhou Medical University, Guiyang 550000, China. fanglili990538@163.com."}], "LastName": "Fang", "ForeName": "Li-Li", "Initials": "LL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China. sbf565912218@163.com."}, {"Identifier": [], "Affiliation": "Department of Anatomy, Guizhou Medical University, Guiyang 550000, China. sbf565912218@163.com."}], "LastName": "Sun", "ForeName": "Bao-Fei", "Initials": "BF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China. hlrong126@163.com."}, {"Identifier": [], "Affiliation": "Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550002, China. hlrong126@163.com."}], "LastName": "Huang", "ForeName": "Li-Rong", "Initials": "LR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China. yhb717697@163.com."}, {"Identifier": [], "Affiliation": "Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550002, China. yhb717697@163.com."}], "LastName": "Yuan", "ForeName": "Hai-Bo", "Initials": "HB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China. shushuo@163.com."}, {"Identifier": [], "Affiliation": "Department of Anatomy, Guizhou Medical University, Guiyang 550000, China. shushuo@163.com."}], "LastName": "Zhang", "ForeName": "Shuo", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China. cj375307579@163.com."}, {"Identifier": [], "Affiliation": "Department of Anatomy, Guizhou Medical University, Guiyang 550000, China. cj375307579@163.com."}], "LastName": "Chen", "ForeName": "Jing", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China. xcb@gmc.edu.cn."}, {"Identifier": [], "Affiliation": "Department of Anatomy, Guizhou Medical University, Guiyang 550000, China. xcb@gmc.edu.cn."}], "LastName": "Yu", "ForeName": "Zi-Jiang", "Initials": "ZJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China. cnp@gzcnp.cn."}, {"Identifier": [], "Affiliation": "Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550002, China. cnp@gzcnp.cn."}], "LastName": "Luo", "ForeName": "Heng", "Initials": "H"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "MIRN34 microRNA, human"}, {"RegistryNumber": "0", "NameOfSubstance": "MicroRNAs"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Transforming Growth Factor beta"}, {"RegistryNumber": "0", "NameOfSubstance": "SMAD3 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Smad3 Protein"}, {"RegistryNumber": "0", "NameOfSubstance": "Transforming Growth Factor beta"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Suppressor Protein p53"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Cell Movement"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "MicroRNAs"}, {"QualifierName": [], "DescriptorName": "Neoplasm Metastasis"}, {"QualifierName": ["metabolism", "pathology"], "DescriptorName": "Prostatic Neoplasms"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Receptors, Transforming Growth Factor beta"}, {"QualifierName": ["metabolism"], "DescriptorName": "Smad3 Protein"}, {"QualifierName": ["metabolism"], "DescriptorName": "Transforming Growth Factor beta"}, {"QualifierName": ["metabolism"], "DescriptorName": "Tumor Suppressor Protein p53"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2016. CA Cancer J. Clin. 2016;66:7\u201330. doi: 10.3322/caac.21332.", "ArticleIdList": ["10.3322/caac.21332", "26742998"]}, {"Citation": "Litwin M.S., Tan H. The diagnosis and treatment of prostate cancer: A review. JAMA. 2017;317:2532\u20132542. doi: 10.1001/jama.2017.7248.", "ArticleIdList": ["10.1001/jama.2017.7248", "28655021"]}, {"Citation": "Saad F., Fizazi K. Androgen Deprivation Therapy and Secondary Hormone Therapy in the Management of Hormone-sensitive and Castration-resistant Prostate Cancer. Urology. 2015;86:852\u2013861. doi: 10.1016/j.urology.2015.07.034.", "ArticleIdList": ["10.1016/j.urology.2015.07.034", "26282624"]}, {"Citation": "Barthel S.R., Hays D.L., Yazawa E.M., Opperman M., Walley K.C., Nimrichter L., Burdick M.M., Gillard B.M., Moser M.T., Pantel K., et al. Definition of Molecular Determinants of Prostate Cancer Cell Bone Extravasation. Cancer Res. 2013;73:942\u2013952. doi: 10.1158/0008-5472.CAN-12-3264.", "ArticleIdList": ["10.1158/0008-5472.CAN-12-3264", "PMC3548951", "23149920"]}, {"Citation": "Julius S., Allegrucci C., Boorjian S.A., Mongan N.P., Persson J.L. Overcoming Drug Resistance and Treating Advanced Prostate Cancer. Curr. Drug Targets. 2012;13:1308\u20131323.", "ArticleIdList": ["PMC3474961", "22746994"]}, {"Citation": "Lang L., Shay C., Zhao X., Teng Y. Combined targeting of Arf1 and Ras potentiates anticancer activity for prostate cancer therapeutics. J. Exp. Clin. Cancer Res. 2017;36:112. doi: 10.1186/s13046-017-0583-4.", "ArticleIdList": ["10.1186/s13046-017-0583-4", "PMC5568197", "28830537"]}, {"Citation": "Chen W.Y., Liu S.Y., Chang Y.S., Yin J.J., Yeh H.L., Mouhieddine T.H., Hadadeh O., Abou-Kheir W., Liu Y.N. MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer. Oncotarget. 2015;6:441\u2013457. doi: 10.18632/oncotarget.2690.", "ArticleIdList": ["10.18632/oncotarget.2690", "PMC4381606", "25436980"]}, {"Citation": "Jiang H., Grenley M.O., Bravo M.J., Blumhagen R.Z., Edgar B.A. EGFR/Ras/MAPK signaling mediates adult midgut epithelial homeostasis and regeneration in Drosophila. Cell Stem Cell. 2011;8:84\u201395. doi: 10.1016/j.stem.2010.11.026.", "ArticleIdList": ["10.1016/j.stem.2010.11.026", "PMC3021119", "21167805"]}, {"Citation": "Roberts P.J., Der C.J. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene. 2007;26:3291\u20133310. doi: 10.1038/sj.onc.1210422.", "ArticleIdList": ["10.1038/sj.onc.1210422", "17496923"]}, {"Citation": "Herbst A., Kolligs F.T. Wnt Signaling as a Therapeutic Target for Cancer. In: Sioud M., editor. Target Discovery and Validation Reviews and Protocols: Volume 2: Emerging Molecular Targets and Treatment Options. Humana Press; Totowa, NJ, USA: 2007. pp. 63\u201391.", "ArticleIdList": ["17172707"]}, {"Citation": "Lai E.C., Tomancak P., Williams R.W., Rubin G.M. Computational identification of Drosophila microRNA genes. Genome Biol. 2003;4:R42. doi: 10.1186/gb-2003-4-7-r42.", "ArticleIdList": ["10.1186/gb-2003-4-7-r42", "PMC193629", "12844358"]}, {"Citation": "Bartel D.P. MicroRNAs. Cell. 2017;116:281\u2013297. doi: 10.1016/S0092-8674(04)00045-5.", "ArticleIdList": ["10.1016/S0092-8674(04)00045-5", "14744438"]}, {"Citation": "Miranda K.C., Huynh T., Tay Y., Ang Y.S., Tam W.L., Thomson A.M., Lim B., Rigoutsos I. A Pattern-Based Method for the Identification of MicroRNA Binding Sites and Their Corresponding Heteroduplexes. Cell. 2006;126:1203\u20131217. doi: 10.1016/j.cell.2006.07.031.", "ArticleIdList": ["10.1016/j.cell.2006.07.031", "16990141"]}, {"Citation": "Lewis B.P., Burge C.B., Bartel D.P. Conserved Seed Pairing, often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets. Cell. 2005;120:15\u201320. doi: 10.1016/j.cell.2004.12.035.", "ArticleIdList": ["10.1016/j.cell.2004.12.035", "15652477"]}, {"Citation": "Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834\u2013838. doi: 10.1038/nature03702.", "ArticleIdList": ["10.1038/nature03702", "15944708"]}, {"Citation": "Liu C., Kelnar K., Liu B., Chen X., Calhoun-Davis T., Li H., Patrawala L., Yan H., Jeter C., Honorio S., et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat. Med. 2011;17:211\u2013215. doi: 10.1038/nm.2284.", "ArticleIdList": ["10.1038/nm.2284", "PMC3076220", "21240262"]}, {"Citation": "Gandellini P., Folini M., Longoni N., Pennati M., Binda M., Colecchia M., Salvioni R., Supino R., Moretti R., Limonta P., et al. miR-205 Exerts Tumor-Suppressive Functions in Human Prostate through Down-regulation of Protein Kinase C\u03b5. Cancer Res. 2009;69:2287\u20132295. doi: 10.1158/0008-5472.CAN-08-2894.", "ArticleIdList": ["10.1158/0008-5472.CAN-08-2894", "19244118"]}, {"Citation": "Takeshita F., Patrawala L., Osaki M., Takahashi R., Yamamoto Y., Kosaka N., Kawamata M., Kelnar K., Bader A.G., Brown D., et al. Systemic Delivery of Synthetic MicroRNA-16 Inhibits the Growth of Metastatic Prostate Tumors via Downregulation of Multiple Cell-cycle Genes. Mol. Ther. 2010;18:181\u2013187. doi: 10.1038/mt.2009.207.", "ArticleIdList": ["10.1038/mt.2009.207", "PMC2839211", "19738602"]}, {"Citation": "He L., He X., Lim L.P., de Stanchina E., Xuan Z., Liang Y., Xue W., Zender L., Magnus J., Ridzon D., et al. A microRNA component of the p53 tumour suppressor network. Nature. 2007;447:1130\u20131134. doi: 10.1038/nature05939.", "ArticleIdList": ["10.1038/nature05939", "PMC4590999", "17554337"]}, {"Citation": "Ellsworth R.E., Vertrees A., Love B., Hooke J.A., Ellsworth D.L., Shriver C.D. Chromosomal Alterations Associated with the Transition from In Situ to Invasive Breast Cancer. Ann. Surg. Oncol. 2008;15:2519\u20132525. doi: 10.1245/s10434-008-0051-7.", "ArticleIdList": ["10.1245/s10434-008-0051-7", "18622645"]}, {"Citation": "Rasio D., Negrini M., Manenti G., Dragani T.A., Croce C.M. Loss of Heterozygosity at Chromosome 11q in Lung Adenocarcinoma: Identification of Three Independent Regions. Cancer Res. 1995;55:3988\u20133991.", "ArticleIdList": ["7664268"]}, {"Citation": "Dahiya R., McCarville J., Lee C., Hu W., Kaur G., Carroll P., Deng G. Deletion of chromosome 11p15, p12, q22, q23-24 loci in human prostate cancer. Int. J. Cancer. 1997;72:283\u2013288. doi: 10.1002/(SICI)1097-0215(19970717)72:2<283::AID-IJC14>3.0.CO;2-H.", "ArticleIdList": ["10.1002/(SICI)1097-0215(19970717)72:2<283::AID-IJC14>3.0.CO;2-H", "9219834"]}, {"Citation": "Navarro F., Lieberman J. miR-34 and p53: New Insights into a Complex Functional Relationship. PLoS ONE. 2015;10:e0132767. doi: 10.1371/journal.pone.0132767.", "ArticleIdList": ["10.1371/journal.pone.0132767", "PMC4503669", "26177460"]}, {"Citation": "Ebner O.A., Selbach M. Quantitative Proteomic Analysis of Gene Regulation by miR-34a and miR-34c. PLoS ONE. 2014;9:e92166. doi: 10.1371/journal.pone.0092166.", "ArticleIdList": ["10.1371/journal.pone.0092166", "PMC3956911", "24637697"]}, {"Citation": "Prokopi M., Kousparou C.A., Epenetos A.A. The Secret Role of microRNAs in Cancer Stem Cell Development and Potential Therapy: A Notch-Pathway Approach. Front. Oncol. 2015;4 doi: 10.3389/fonc.2014.00389.", "ArticleIdList": ["10.3389/fonc.2014.00389", "PMC4324081", "25717438"]}, {"Citation": "Hermeking H. MicroRNAs in the p53 network: Micromanagement of tumour suppression. Nat. Rev. Cancer. 2012;12:613\u2013626. doi: 10.1038/nrc3318.", "ArticleIdList": ["10.1038/nrc3318", "22898542"]}, {"Citation": "Tarasov V., Jung P., Verdoodt B., Lodygin D., Epanchintsev A., Menssen A., Meister G., Hermeking H. Differential Regulation of microRNAs by p53 Revealed by Massively Parallel Sequencing: miR-34a is a p53 Target That Induces Apoptosis and G1-arrest. Cell Cycle. 2007;6:1586\u20131593. doi: 10.4161/cc.6.13.4436.", "ArticleIdList": ["10.4161/cc.6.13.4436", "17554199"]}, {"Citation": "Rokavec M., Li H., Jiang L., Hermeking H. The p53/miR-34 axis in development and disease. J. Mol. Cell Biol. 2014;6:214\u2013230. doi: 10.1093/jmcb/mju003.", "ArticleIdList": ["10.1093/jmcb/mju003", "24815299"]}, {"Citation": "Hagman Z., Haflidadottir B.S., Ansari M., Persson M., Bjartell A., Edsj\u00f6 A., Ceder Y. The tumour suppressor miR-34c targets MET in prostate cancer cells. Br. J. Cancer. 2013;109:1271\u20131278. doi: 10.1038/bjc.2013.449.", "ArticleIdList": ["10.1038/bjc.2013.449", "PMC3778300", "23922103"]}, {"Citation": "Aalinkeel R., Nair M.P., Sufrin G., Mahajan S.D., Chadha K.C., Chawda R.P., Schwartz S.A. Gene Expression of Angiogenic Factors Correlates with Metastatic Potential of Prostate Cancer Cells. Cancer Res. 2004;64:5311\u20135321. doi: 10.1158/0008-5472.CAN-2506-2.", "ArticleIdList": ["10.1158/0008-5472.CAN-2506-2", "15289337"]}, {"Citation": "Majid S., Dar A.A., Saini S., Shahryari V., Arora S., Zaman M.S., Chang I., Yamamura S., Tanaka Y., Chiyomaru T., et al. miRNA-34b Inhibits Prostate Cancer through Demethylation, Active Chromatin Modifications, and AKT Pathways. Clin. Cancer Res. 2012;19:73\u201384. doi: 10.1158/1078-0432.CCR-12-2952.", "ArticleIdList": ["10.1158/1078-0432.CCR-12-2952", "PMC3910324", "23147995"]}, {"Citation": "Hagman Z., Larne O., Edsj\u00f6 A., Bjartell A., Ehrnstr\u00f6m R.A., Ulmert D., Lilja H., Ceder Y. miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions. Int. J. Cancer. 2010;127:2768\u20132776. doi: 10.1002/ijc.25269.", "ArticleIdList": ["10.1002/ijc.25269", "21351256"]}, {"Citation": "Chaffer C.L., Weinberg R.A. A Perspective on Cancer Cell Metastasis. Science. 2011;331:1559\u20131564. doi: 10.1126/science.1203543.", "ArticleIdList": ["10.1126/science.1203543", "21436443"]}, {"Citation": "Bellomo C., Caja L., Moustakas A. Transforming growth factor \u03b2 as regulator of cancer stemness and metastasis. Br. J. Cancer. 2016;115:761\u2013769. doi: 10.1038/bjc.2016.255.", "ArticleIdList": ["10.1038/bjc.2016.255", "PMC5046208", "27537386"]}, {"Citation": "Folkman J., Klagsbrun M. Angiogenic factors. Science. 1987;235:442\u2013447. doi: 10.1126/science.2432664.", "ArticleIdList": ["10.1126/science.2432664", "2432664"]}, {"Citation": "Miguchi M., Hinoi T., Shimomura M., Adachi T., Saito Y., Niitsu H., Kochi M., Sada H., Sotomaru Y., Ikenoue T. Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor \u03b2 Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation. PLoS ONE. 2016;11:e0166422. doi: 10.1371/journal.pone.0166422.", "ArticleIdList": ["10.1371/journal.pone.0166422", "PMC5105946", "27835699"]}, {"Citation": "Tian A., Ma H., Zhang R., Tan W., Wang X., Wu B., Wang J., Wan C. Interleukin17A Promotes Postoperative Cognitive Dysfunction by Triggering \u03b2-Amyloid Accumulation via the Transforming Growth Factor-\u03b2 (TGF\u03b2)/Smad Signaling Pathway. PLoS ONE. 2015;10:e0141596. doi: 10.1371/journal.pone.0141596.", "ArticleIdList": ["10.1371/journal.pone.0141596", "PMC4624903", "26509545"]}, {"Citation": "Choi Y.J., Lin C.-P., Ho J.J., He X., Okada N., Bu P., Zhong Y., Kim S.Y., Bennett M.J., Chen C., et al. miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat. Cell Biol. 2011;13:1353\u20131360. doi: 10.1038/ncb2366.", "ArticleIdList": ["10.1038/ncb2366", "PMC3541684", "22020437"]}, {"Citation": "Forno I., Ferrero S., Russo M.V., Gazzano G., Giangiobbe S., Montanari E., Del Nero A., Rocco B., Albo G., Languino L.R., et al. Deregulation of MiR-34b/Sox2 Predicts Prostate Cancer Progression. PLoS ONE. 2015;10:e0130060. doi: 10.1371/journal.pone.0130060.", "ArticleIdList": ["10.1371/journal.pone.0130060", "PMC4479381", "26107383"]}, {"Citation": "Lan H.Y. Diverse Roles of TGF-\u03b2/Smads in Renal Fibrosis and Inflammation. Int. J. Biol. Sci. 2011;7:1056\u20131067. doi: 10.7150/ijbs.7.1056.", "ArticleIdList": ["10.7150/ijbs.7.1056", "PMC3174390", "21927575"]}, {"Citation": "Yang H., Fang F., Chang R., Yang L. MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor \u03b2 receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma. Hepatology. 2013;58:205\u2013217. doi: 10.1002/hep.26315.", "ArticleIdList": ["10.1002/hep.26315", "23401231"]}, {"Citation": "Wu K., Zhao Z., Ma J., Chen J., Peng J., Yang S., He Y. Deregulation of miR-193b affects the growth of colon cancer cells via transforming growth factor-\u03b2 and regulation of the SMAD3 pathway. Oncol. Lett. 2017;13:2557\u20132562. doi: 10.3892/ol.2017.5763.", "ArticleIdList": ["10.3892/ol.2017.5763", "PMC5403328", "28454433"]}]}], "History": [{"Year": "2017", "Month": "10", "Day": "30"}, {"Year": "2017", "Month": "12", "Day": "11"}, {"Year": "2017", "Month": "12", "Day": "12"}, {"Year": "2017", "Month": "12", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "12", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "7", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "12", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["29257105", "PMC5751361", "10.3390/ijms18122762", "ijms18122762"]}}]}